Polycystic Ovarian Syndrome (PCOS) in
Adolescence
Dr. Mrs. S. Anuchithra Radhakrishnan,
Vice Principal and HOD, OBG
Nursing, P.D. Bharatesh College of Nursing, Halaga, Belgaum, Karnataka.
*Corresponding Author Email: anuchithra7377@yahoo.co.in
INTRODUCTION:
Follicles of the ovary are the basic unit
of female reproductive biology. They are usually round and contain a single egg
or ovum. Normal ovarian volume in the menstruating females is 5-15 mL, with an approximate mean of 10 ml. Polycystic
ovary syndrome (PCOS) is the leading cause of menstrual irregularities and hyperandrogenism in adolescents. In addition, it is the most common hormonal
disorder in obesity and one of the most common causes of infertility in women.
Although it was traditionally thought to be a problem of adulthood, it is now
known that its onset takes place in childhood. It should be considered in any
adolescent with hirsutism, persistent acne,
dysfunctional uterine bleeding and/or obesity.
The identification of each of these complaints is a
challenge in adolescence. On the other hand, diagnosis of PCOS has long term
implications with increased risk of infertility, metabolic syndrome, type2
diabetes (T2DM) and cardiovascular disease. Increasing prevalence of obesity in
adolescence has generated a growing concern with the increase of PCOS at this
age. Although obesity is not a feature of the syndrome, it affects the degree
of insulin resistance, worsening metabolic and reproductive characteristics.
There is strong evidence that obesity increase severity
of clinical manifestations of PCOS and the risk of metabolic dysfunction. In
adolescents, as in adult women, there is a positive association between body
mass index (BMI) and androgen levels. On the other hand, weight loss is
associated with a decrease in testosterone.
Increase
in child hood obesity worsens the symptoms of PCOS in adolescence, although it
is unlikely that it increases the prevalence of this syndrome. In other words,
obesity seems to unmask young people who were otherwise asymptomatic and are
now presenting with symptoms of androgen excess and anovulation.
Long-term monitoring of women with PCOS revealed that 40% of those affected
develop type2 diabetes or impaired glucose tolerance at the age of 40. The risk
of developing type 2 diabetes is 10 times higher in patients with PCOS, which
represents a public health problem and an opportunity for early intervention.
Nomenclature:
Other names of PCOS are;
·
Polycystic
ovary disease,
·
Functional
ovarian hyperandrogenism,
·
Hyperandrogenic chronic anovulation,
·
Ovarian
dysmetabolic syndrome,
·
Polycystic
ovarian syndrome
·
Stein-Leventhal syndrome.
Definition of PCOS in Adolescence:
Under
the criteria of the National Institutes of Health (NIH), PCOS was defined as
the presence of oligoovulation /anovulation
and clinical or biochemical hyperandrogenism, not
explained by other causes. 2003, a new
consensus between the European Society of Human Reproduction and Embryology and
the American Society of Reproductive Medicine established the Rotterdam
criteria, defining PCOS when at least 2 of these 3 criteria are present, after
exclusion of other diseases as with similar phenotypes.
|
Rotterdam |
Rotterdam diagnostic criteria requires two of; 1. Oligo or anovulation; 2. Clinical and/or biochemical signs of hyperandrogenism; 3. Plycystic ovaries; and exclusion of other aetiologies such as
hypothyroidism, hypoprolactinemia, congenital
adrenal hyperplasia, androgen – secreting tumors and cushing’s
syndrome (14) |
||
|
NIH |
NIH diagnostic criteria
requires; 1. Oligo or anovulation; and 2. Clinical and/or biochemical signs of hyperandrogenism; And exclusion of other aetiologies such as
congenital adrenal hyperplasia, angrogen-secreting tumours and Cushing’s syndrome (15). |
|
|
|
|
|
||
There
are no diagnostic criteria specifically defined for adolescence, when
physiological and anatomical changes make this diagnosis a challenge. First, it
is difficult to distinguish between physiological an ovulation often found in
puberty and an ovulation of PCOS. In healthy adolescents, half of the cycles
are an ovulatory in the first year after menarche.
Secondly, the definition of polycystic ovary in adolescence is difficult. The
frequent occurrence of multiple follicles during adolescence may be misleading
with the appearance of multicystic ovaries, a normal
adolescent variant. Furthermore, the use
of abdominal instead of transvaginal route in teenage
virgins decreases sensitivity of ultrasound.
Finally, a slight acne and hirsutism are
common and there might be a transient functional hyperandrogenism
during adolescence.
Incidence:
![]()
PCOS or Polycystic ovarian syndrome is a heterogeneous
complex metabolic, endocrine, reproductive disorder. Most
studies note that polycystic ovaries are present in 3-7% of women worldwide. In
India it is estimated that the incidence is higher and probably three times
more than that found in the western world. PCOS affecting 9.13% Indian
adolescents, about 2.2% to 26% women in the age range of 18 to 45 years in India.
PCOS can be a frustrating experience for women, a complex syndrome for
clinicians and a scientific challenge for researchers, and is a major public
health concern.
Polycystic
ovarian syndrome (PCOS) accounts for – 90% of women with infrequent periods (or
oligomenorrhea), 30% of women with absence of periods
(or amenorrhea) and Over 70% of women with anovulation
– no production of eggs during periods.
|
Medscape |
|||||||||||||||
|
PCOS: changing women’s
health paradigm |
|||||||||||||||
|
|
|||||||||||||||
|
|
Metabolic
disease Reproductive
disorders |
||||||||||||||
|
(Young age) |
|
(Older age) |
|||||||||||||
|
Menstrual disorder Hirsutism Contraception Sexual health Infertility |
à |
Pregnancy complications Quality of life Type 2 diabetes Cardiovascular disease Cancer risk |
|||||||||||||
|
Multi – disciplinary
approaches |
|||||||||||||||
|
Pediatrics |
à |
Dermatology |
à |
Gynecology |
à |
Endocrinology |
à |
Diabetology |
à |
Cardiology |
à |
Geriatry |
|||
|
Source: Hum Reprod @ 2011
Oxford University Press |
|||||||||||||||
Schematic representation of
the change in emphasizes from early age reproductive disorders to long-term
metabolic and cardiovascular health.
Normal physiology and Mechanism:
![]()
The hormones in
human bodies are regulated by two regions of the brain – the hypothalamus and
the pituitary gland. Hormones are chemicals that are secreted in miniscule
amounts and a very small imbalance in their secretions can lead to different
problems that can manifest as diseases.
Understanding
the cause of polycystic ovaries requires some basic understanding of how the
hormones are normally regulated. In the normal physiology / state
Hypothalamus
Gonadotropin-releasing hormone (GnRH), Luteinizing
hormone (LH) and Follicle-Stimulating Hormone (FSH) from the pituitary gland, acts
on certain cells of the ovary.
Estrogen and
progesterone, the female sex hormones (and also make a little bit of the androgen
testosterone, a male sex hormone).
Bring about maturation of the follicle and results in
release of eggs.
The
pancreas is an organ that makes the hormone insulin. High levels of insulin can
also cause the ovaries to make more of the hormone testosterone.
Review of
Regular Menstrual Cycle:
1. The menstrual cycle starts when the brain
sends LH and FSH to the ovaries. A big surge of LH is the signal that tells the
ovaries to ovulate, or release an egg.
2. The egg travels down the fallopian tube and
into the uterus. Progesterone from the ovary tells the lining of the uterus to
thicken.
3. If the egg isn't fertilized, the lining of
the uterus is shed. This is a menstrual period.
4. After the menstrual period, the cycle
begins all over again.
PCOS Cycle with no Ovulation:
Girls with PCOS may ovulate
occasionally or not at all, so periods may be too close together, or more
commonly too far apart. Some girls may not get a period at all.
In polycystic
ovaries syndrome, the cycle is disturbed. Evaluation of blood serum levels
typically reveals elevated LH levels and normal or low FSH levels. Patients
also have increased levels of free estrogen (primarily estrone
and estradiol) and testosterone levels.
The lack of
follicle maturation and the inability to ovulate are likely caused by low
levels of follicle stimulating hormone (FSH) , and higher-than-normal levels of
androgens (male hormones), produced in the ovary.
1. With PCOS, LH levels are often high when
the menstrual cycle starts. The levels of LH are also higher than FSH levels.
2. Because the LH levels are already quite
high, there is no LH surge. Without this LH surge, ovulation does not occur,
and periods are irregular
Causes:
![]()
The proposed causes of polycystic ovaries
are briefly listed below:
·
Ovary hormones
·
Increased androgen production
·
Disturbances in the cyclic pattern of GnRH
release by the hypothalamus
·
Insulin resistance
·
Autosomal dominant
transmission
a. Ovary hormones:
Hormones
are not in adequate levelsLack of maturation of
follicle
Inability to ovulate.
b. Increased androgen production: The adrenal glands at puberty Increased androgen.High androgen levels in a woman causes hirsutism and acne problems and can stop ovulation.
c.
Disturbances in the cyclic pattern of GnRH release by the hypothalamus
d.
Insulin resistance: Inadequate
response to insulin can lead to abnormally elevated blood sugar (glucose)
levels. The insulin disturbance is also being the trigger for the development
of symptoms such as acne and excess hair growth that is seen with PCOS.
e.
Autosomal dominant transmission: There is not yet enough evidence to say
there is a genetic link to this disorder. Women with PCOS frequently have a
familial history of PCOS.
The etiological, hormonal
and clinical features of polycystic ovary syndrome are;
Pathophysiology:
PCOS
seems to be a malfunction with ovarian overproduction of androgens in
genetically determined women. The heterogeneity of clinical manifestations may
be explained by interaction of the disease with environment, mainly diet. The
genesis of PCOS appears to begin much earlier than in adolescence, possibly
even in intrauterine life. One of the early manifestations of PCOS can be
premature pubarche (appearance of pubic hair before 8
years old).
A
low weight at birth and a rapid recovery (catch-up) of weight in early life are
associated with an increased risk of premature pubarche
and precocious puberty. Among girls with pre- mature pubarche,
those with a history of low birth weight, even if not obese, have the greatest hyperinsulinism and a greater risk of developing a variant
of PCOS with hyper- insulinemic hyperandrogenism,
dyslipidemia and central obesity.
The
complete clinical syndrome is manifested with maturation of the
hypothalamic–pituitary–ovary axis that occurs in puberty. The increase of LH
circulating levels, characteristic of puberty, is exaggerated in girls with
predisposition for PCOS, increasing the production of androgens by the ovary.
The presentation in adolescence is also affected by metabolic changes associated
with body fat distribution.
The
hyperinsulinism leads to suppression of hepatic
production of SHBG, which amplifies the effects of steroid hormones, with
higher free testosterone concentrations.
Maturation of the hypothalamic–pituitary–ovary
axis in puberty.
LH
circulating levels (characteristic of puberty), is exaggerated in girls with
PCOS,
Production of androgens by ovary.
Metabolic
changes associated with body fat distribution
Higher
insulin resistance
Hyperinsulinism
Suppression
of hepatic production of Sex Hormone -Binding- Globulin ( SHBG- glycol protein
binds to sex hormone, to be specific-Testosterone, Estradiol,
Progesterone, Cortisol and Corticosteroids are bound
by trans scartin) (which amplifies the effects of
steroid hormones, with higher free testosterone concentrations)
In
addition, insulin increases steroidogenic response of
thecal cells to luteinizing hormone (LH), stimulating
the production of ovarian androgens.
Normal
puberty and adolescence are associated with increased insulin resistance and
increased fasting insulin concentrations. Women with PCOS, whether lean or
obese, have higher insulin resistance than women without PCOS of similar
weight. Furthermore, studies show worsening of insulin resistance with
overweight and obesity associated with PCOS. The main source of hyperandrogenemia in PCOS is the ovary. Abnormally high
levels of insulin, either by genetic predisposition or by excessive weight
gain, or both, will increase these potential adverse effects. Despite a state
of insulin resistance in other tissues, ovarian steroidogenic
response to insulin is maintained.
Clinical Features PCOS:
![]()
In
PCOS, symptoms start slowly and progressively. In adolescence can manifest in
different forms, including hirsutism, menstrual irregularity,
acanthosis nigricans
(Thickened brown velvety textured patches of skin that may occur in any
location but most commonly appear in the folds of the skin in the armpit, groin
and back of the neck) and precocious pubarche and /
or puberty.
Moreover,
persistent acne or hair loss can be the main complaints of these adolescents.
Sudden appearance and rapid progression of hirsutism
or virilization (Virilization
is when a female develops male sex characteristics) point to other diagnosis,
such as an androgen producing tumor.
Obesity:
§ Tables of percentiles (P) for BMI should be used as
they are the only correct way to identify obesity and over weight in this age
group. Obesity is defined when BMI is above the 95th percentile and
overweight when BMI is between the 85th and 95th
percentiles for age and sex.
Hyperandrogenism:
§ Hirsutism: Hirsutism is defined as the presence of terminal hair that
appears excessively in a male pattern in women. Terminal hair is the thick,
long and pigmented hair that normally exists in the pubic and axillary areas after puberty. One must distinguish between hirsutism and hypertrichosis.
erminal
hair is longer, coarser, and darker than vellus hair
Hypertrichosis is a condition of excessive hair growth in a generalized distribution
that can be inherited or secondary to the use of certain drugs. In the
assessment of hirsutism it is important to know the
treatments previously carried out to remove hair. Even taking in to account its
limitations, the Ferriman–Gallwey scale (Figure1) is
useful to confirm and monitor hirsutism. According to
the Endocrine Society guidelines published in 2008 Hirsutism
is indicated by a Ferriman–Gallwey hirsutism score >8.
Hirsutism equivalents:
Hirsutism
and its equivalents represent manifestations of excess androgens that are
present in 2/3 of women with biochemical hyperandrogenism.
Not all hirsutismis caused by hyperandrogenism.
About ½ of women with mild hirsutism and 1/6 of those
with moderate hirsutism donot
have hyperandrogenism. PCOS is the most common cause
of hyperandrogenemia. Other causes are rare: They are
Non-classic congenital adrenal hyperplasia, Androgen-secreting tumors, hyperprolactinemia, and Cushing’s syndrome, acromegaly and thyroid dysfunction.
Menstrual irregularities:
Menstrual
cycles of adolescents, especially in the first year after menarche, may be anovulatory and irregular. However, it is a myth that they
are completely chaotic. By the third year after menarche, 95% of menstrual
cycles have an expected duration between 21 and 45 days and the bleeding lasts
2 to 7 days. Menstrual irregularities that remain 2 years after menarche are
associated with PCOS in about 70% of cases.
A
menstrual flow greater than 80mL per cycle or a subjective impression of
heavier than normal flow (more than 6 full pads or tampons per day) is
considered abnormal. Abnormal uterine bleeding is among the most frequent
complaints of adolescents. The majority of cases related to anovulatory
cycles in the first 12–18 months after menarche due to immaturity of the
hypothalamic–pituitary–ovarian axis also called dysfunctional uterine bleeding.
Other causes include pregnancy, oral contraceptives and endocrine disorders
(PCOS, hypothyroidism, hyperprolactinemia).
Diagnosis:
Typically this evaluation includes the following tests.
·
Pnancy test, if amenorrhoea.
·
Pelvic
ultrasound. - Bilaterally enlarged
cystic ovaries with > 8 follicles per ovary, with less than 10 mm in
diameter. > 90 % of PCOS - present in USG. Multiple follicles - ‘‘string of
pearls’’ on USG. Transvaginal approach has allowed
better delineation of multiple follicular cysts.
·
Prolactin to exclude hyperprolactinemia.
It can manifest with oligomenorrhea or amenorrhea and
/ or galactorrhea.
·
DHEAS (Dehydro Epiandrosteron Sulphate – secreted by adrenal glands- evaluate adrenal
gland function) and
17- OH – progesterone
(between 7 and 8 a.m.) in the follicular phase of the menstrual cycle to
exclude adrenal hyperandrogenism.
·
Assessment for
Cushing’s syndrome, thyroid dysfunction or growth hormone excess, if other
clinical features are present:
·
TSH if menstrual
irregularities, symptoms or signs of thyroid dysfunction.
·
Insulin-like
growth factor 1(IGF-1) if growth hormone excess is suspected.
·
Urinary free cortisol (24-hurine) if hyperandrogenism,
menstrual irregularities, violaceous striae (wider than 1cm striae in
the abdomen-manifestation of Cushing’s syndrome), central obesity.
Ferriman–Gallwey hirsutism scoring system. Each of the nine body areas most sensitive to androgen is assigned a
score from 0 (no hair) to 4 (frankly virile), and these separate scores are
summed to provide a hormonal hirsutism score.
[Reproduced from Evaluation and treatment of hirsutism
in premenopausal women: an Endocrine Society Clinical Practice Guideline].
Some
extremely rare cases will be clarified only with more specific tests such as dexamethasone suppression or Corticotropin
(ACTH) stimulation tests, as suggested by the American Society for Reproductive
Medicine.
For
confirmation of anovulation, measurement of
progesterone between the 22th and 24th days of menstrual cycle can
be useful.
Additional:
Other
tests should be considered according to the clinical picture. In the presence
of rapidly progressive hirsutism or signs of virilization, computed tomographic
scans (CT) or magnetic resonance imaging (MRI) of adrenal glands are also
essential for diagnosis of an adrenal tumor. As women with PCOS are
particularly prone to develop metabolic syndrome (MS), we must not forget to
measure blood pressure, waist circumference, fasting glucose and lipid profile
and to perform an oral glucose tolerance test (OGTT).
Thus,
in the presence of PCOS, OGTT should be performed even in the presence of a
normal fasting glucose, regardless of the presence of obesity. These are also
the recommendations of the American Society for Reproductive Medicine published
in late 2008.
Treatment:

The
treatment of adolescents with PCOS has focused on short-term aspects. The goal
of treatment is not related to infertility in this age group. Short -term
aspects such as self-esteem, acne and hirsutism
improvement, weight control and menstrual cycles
regulation. It is important, however, to stress that the treatment should also
take into account long-term aspects such as reducing the risk of type 2
diabetes mellitus and cardiovascular disease.
The
treatment should be individualized according to co- morbid conditions (e.g.
obesity) and the goals to be achieved. Given the strong evidence that hyperinsulinemia plays a key role in the pathogenesis of
PCOS, targeted interventions aiming changes in lifestyle are essential. Weight
reduction with dietary interventions is effective in reducing androgens levels
and in regulating menstrual cycles.
Reduction
of testosterone concentrations and regulation of menstrual cycles are
associated with losses of about 5–7% of bodyweight. Above all, changes in
lifestyle are the cornerstone of treatment to reduce the risk of type 2
diabetes mellitus and cardiovascular disease.
Medical
Therapy:
Oral
contraceptives:
For
most pediatric endocrinologists, oral contraceptives are considered first-line drugs in the treatment of adolescents with PCOS.
The
menstrual irregularities should be treated, as chronic anovulation
increases the risk of endometrial hyperplasia, which is associated with
endometrial carcinoma. Moreover, in some cases, dysfunctional bleeding or menorrhagia can lead to anemia.
The
estrogenic component suppresses LH and thus production of androgens by ovaries
and increases production of SHBG, resulting in lower concentrations of free
testosterone.
The
estrogenic component suppresses LH and production of androgens by ovaries, Increases
production of SHBG, Lower concentrations of free testosterone.
Estroprogestatives also inhibits 5-alpha-reductase in the skin, lowering levels of dihydrotestosterone. There is a normalization of androgen
levels in18–21 days of treatment in most cases. There is a normalization of
androgen levelsin18–21 days of treatment in most cases. Estroprogestatives
can be used with 30–35 mg or lower doses of 20 mg of ethinyl
estradiol for improvement of hyperandrogenism. Both preparations appear to be similar in
terms of effectiveness atleast regarding the
improvement of acne.
Anti-androgens:
o Used to control the growth of terminal hair
o It may take 9–18 months of treatment to check effects
o Cyproterone acetate
o Spironolactone - dose of 50 mg bid, 100 mg bid for a greater effect.
o Flutamide
o Finasteride - 5 alpha reductase type 2
inhibitor
There
is only limited information about the use of Flutamide
and Finasteride in adolescence.
Metformin in
adolescents with polycystic ovary syndrome:
Oral
contraceptives donot address and may even worsen
metabolic complications of PCOS, although these data are controversial.
It inhibits hepatic glucose production and improves
sensitivity of peripheral tissues to insulin.
It also decreases
appetite and promotes weight loss.
It inhibits hepatic
glucose production and improves sensitivity of peripheral tissues to insulin.
Metformin improves insulin levels, reduces androgens and
regulates menstrual cycles in patients with PCOS, not only in adulthood, but
also in adolescence.
Metformin may be beneficial in some children even before
menarche.
Glitazones replace metformin
Studies in children with premature pubarche
and a history of low birth weight demonstrated the efficacy of metformin in delaying menarche.
Some studies have shown the effectiveness of metformin in preventing PCOS progression for non-obese
individuals with a history of low birth weight and premature pubarche.
Improved metabolic profile disappeared after
discontinuation of therapy in these adolescents.
In a study of obese adolescents with PCOS, metformin has been effective in improving menstrual cycles,
decreasing androgens, improving hirsutism and acne,
and in weight reduction, and these effects persisted 6 months after
discontinuation.
According
to the recommendations of the American Society for Reproductive Medicine
·
Adolescents with
PCOS should perform an OGTT every 2 years for screening glucose tolerance
abnormality;
·
Metformin may be considered in patients with PCOS and abnormal
glucose tolerance;
·
Donot have to recommend metformin
as first-line therapy in PCOS when the sole purpose is to prevent long-term
complications such as T2 DM or cardiovascular disease; in the mean - while,
lifestyle changes should take that place;
·
The first-line
therapy for ovulation induction in patients with PCOS who wish to become
pregnant is clomiphene citrate, and combination with metformin can be useful in refractory cases.
Cosmetic Treatments:
Patients
often want to be counseled about permanent hair removal. Techniques commonly
referred to as ‘‘permanent hair removal’’ are the hair removal laser/pulsed
light and electrolysis. Topical eflornithine, which
slows hair growth, is approved by the Food and Drug Administration (FDA) for
reduction of unwanted facial hair in women.
Topical
treatments for acne can be used in combination with oral contraceptives.
Topical retinoids are indicated in all types of acne.
Topical antibiotics such as benzoyl peroxide have
been helpful in mild to moderate inflammatory acne. Oral isotretinoin
is associated with several side effects and has a high teratogenic
potential that remains at 6 weeks after completion of treatment; it is reserved
for severe cases.
Dietary Guidelines to Combat
PCOS :
A few dietary guidelines to combat PCOS
1.
Try to select
lower glycemic index foods such as whole grains (jowar, bajra, whole wheat, green
vegetables, etc) as they will cause a slower rise in blood sugar levels. For
example, oat flakes or wheat daliah (10 gm fiber/1/2
cup) has a lower glycemic index than cornflakes (1 gm
fiber/1/2 cup). Simply put, add fiber in diet by selecting wheat breads over
white breads, wheat rotis over rice or maida naans, fresh fruits over
fruit juices.
2.
Do cut down
carbohydrate levels so low level of ketosis induced. Try to space the
carbohydrates evenly through the day and eat small and frequent meals rather
than 3 large meals.
3.
Restrict intake of
those carbohydrates that trigger more hunger or cravings (i.e. refined sugar,
sweets, candies or chocolates which triggers craving for some people). Choose
dates or honey to meet sugar cravings.
4.
Suggested vitamin
/ mineral supplements: Taking calcium 1000 mg - 1500 mg (take two - three 500
mg pills a day as prescribed but be sure to space them out as only absorb 500
mg at a time). Add a multivitamin with minerals like folic acid, especially so,
if trying to get pregnant.
5.
Drink at least
8-10 glasses of water per day as a high fiber carbohydrate intake can cause
dehydration.
6.
For heart health,
limit foods high in saturated and trans-fats (i.e., whole milk and products,
butter, red meat, fried foods, rich desserts, etc.). Select mainly
monounsaturated fats (i.e. olive oil, canola oil, nuts) and omega 3 fats -fatty
fish (such as bangda, rohu,
sardines, and surmai), flaxseed, and nuts as these
fats are heart friendly.
Prognosis:
![]()
Untreated polycystic ovary syndrome may be
regarded as a disorder that progresses until the time of menopause. The
long-term consequences for PCOS are - Infertility, Recurrent spontaneous
abortion, Depression/anxiety, Abnormal lipid levels (Dyslipidemia),
Hypertension, Type 2 diabetes mellitus, Coronary artery disease, Cerebrovascular accidents, Endometrial cancer.
PCOS maybe exist in three forms – mild,
moderate and severe and the prognosis varies accordingly. In the mild forms
of PCOD, the affected woman may have - No abnormality of menstruations and
may ovulate normally. It often takes these women longer than normal to conceive
and has a higher chance of spontaneous miscarriage. In moderate PCOD –
There are menstrual irregularities or absence of menstruation and failure of
ovulation. The most severe form of PCOD is characterized by- Obesity, hirsutism, amenorrhea and infertility.
Possible Nursing Diagnosis of PCOS:
Disturbed body image – hirsutism,
male features
Sexual dysfunction – menstrual
irregularities
Impaired tissue integrity – Acne, acanthosis nigricans
Ineffective health maintenance – obesity
Risk for Imbalanced nutrition more than
body requirement – obesity, Type2 DM
Ineffective coping
Disturbed personal identity
Ineffective sexuality pattern (female)
Risk for situational low self-esteem
Risk for unstable blood glucose
Readiness for enhanced nutrition
Readiness for enhanced hoping
Readiness for enhanced therapeutic management
Readiness for enhanced resilience
Knowledge deficit
CONCLUSION:
PCOS
is a common disease among adolescents and has been increasingly associated with
metabolic and cardiovascular complications in the long term, going beyond
cosmetic and fertility concerns. The prevalence of obesity is increasing,
thereby aggravating the symptoms of these adolescents. The control of obesity
and overweight is essential and should begin as early as possible.
PCOS
may remain unnoticed because symptoms such as menstrual irregularities and acne
are relatively common, with an overlap between symptoms of the syndrome and
physiological changes of puberty. Changes in lifestyle are the first-line
therapy. Depending on symptoms and presence of glucose intolerance, therapeutic
weapons include oral contraceptives, anti-androgens and metformin,
but more studies are needed to clarify the best strategy in the prevention of
metabolic complications in the long term.
REFERENCES:
1.
Ana O et al. Polycystic ovary syndrome: Challenges in adolescence. Endocrinología Nutrition. 57(7); 2010:328-336.
2.
Boyle J. Polycystic ovary syndrome and associated metabolic features in
Indigenous women in the Northern Territory [PhD thesis]. Adelaide: University
of Adelaide, 2011.
3.
Ching H, Burke V, Stuckey B. Quality of life and
psychological morbidity in women with polycystic ovary syndrome: body mass
index, age and the provision of patient information are significant modifiers. Clinical
Endocrinology (Oxf). 66: 2007: 373-379.
4.
Cibula
D, Hill M, Starka L. The best correlation of the new
index of hyperandrogenism with the grade of increased
body hair. Europian Journal of Endocrinology. 143: 2000:405-408.
5.
De Simone M, Verrotti A, Iughetti L, et al.
Increased visceral adipose tissue is associated with increased circulating
insulin and decreased sex hormone binding globulin levels in massively obese
adolescent girls. Journal of Endocrinological
Investigation. 24;
2001:438-444.
6.
Deeks A, Gibson HM, Teede H.
Anxiety and depression in polycystic ovary syndrome: a comprehensive
investigation. Fertility and Sterility. 93; 2010: 2421-2423.
7.
Dr. Michael F C. et al. Assessment and management of polycystic ovary
syndrome: summary of an evidence based guideline. Medical journal of Australia, 195 (6); 2011: 65.
8.
Dunaif
A. Insulin resistance and the polycystic ovary syndrome: mechanism and
implications for pathogenesis. Endocrine Reviews. ; 18; 1997:774-800.
9.
Ehrmann
DA. Polycystic ovary syndrome. The New England Journal of Medicine. 352;2005:1223-1236.
10.
Eisenhardt
S, Schwarzmann N, Henschel
V, et al. Early effects of metformin in women with
polycystic ovary syndrome: a prospective randomized, double-blind,
placebo-controlled trial. The Journal of Clinical Endocrinology and
Metabolism. 91;
2006:946-952.
11.
Glueck
CJ, Wang P, Fontaine R, et al. Metformin to restore
normal menses in oligo-amenorrheic teenage girls with
polycystic ovary syndrome (PCOS). Journal of Adolescent Health. 29; 2001:160-169.
12. Helena JT et al. Assessment and management of
polycystic ovary syndrome: summary of an evidence-based guideline. The Medical Journal of Australia. 195
(6); 2011: S65-S112.
13.
Hillard
PJ. Oral contraceptives and the management of hyperandrogenism-polycystic
ovary syndrome in adolescents. Endocrinology and Metabolism Clinics of
North America. 34;
2005:707-723.
14.
Jonard
S, Robert Y, Cortet C, et
al. Ultrasound examination of polycystic ovaries: is it worth counting the
follicles? Human Reproduction. 18; 2003:598-603.
15. March W, Moore V, Willson K, et al. The prevalence of polycystic ovary
syndrome in a community sample assessed under contrasting diagnostic criteria. Human
Reproduction. 2010;
25: 544-551.
16.
McCartney CR, Prendergast KA, Chhabra S, et al. The association of obesity and hyperandrogenemia during transition in girls: obesity as a
potential factor in the genesis of post pubertal hyperandrogenism.
The Journal Clinical Endocrinology and Metabolism. 91; 2006:1714-1722.
17. Moran L et al. Polycystic
ovary syndrome: a bio-psychosocial understanding in young women to improve
knowledge and treatment options. The Journal of Psychosomatic Obstetrics and
Gynecology. 31; 2010:
24-31.
18. Moran L, Teede
H. Metabolic features of the reproductive phenotypes of polycystic ovary
syndrome. Human Reproduction Update.15; 2009: 477-488.
19. Moran LJ, Misso
ML, Wild RA, Norman RJ. Impaired glucose tolerance, type 2 diabetes and
metabolic syndrome in polycystic ovary syndrome: a systematic review and
meta-analysis. Human Reproduction Update 16; 2010: 347-363.
20. Teede H, Deeks
A, Moran L. Polycystic ovary syndrome: a complex conditions with psychological,
reproductive and metabolic manifestations that impact on health across the
lifespan. BMC Medicine.8;
2010 8: 41.
21.
Trent ME, Rich M, Austin SB,
et al. Quality of life in adolescent girls with polycystic ovary syndrome. Archieves of Pediatric and Adolescent Medicine. 156; 2002:556-560.
22. Monso kohli . How to tackle PCOS
Women’s health: 2011.
23.
http://www.aafp.org/afp/20030815/697.html
24.
http://www.aafp.org/afp/20000901/1079.html
25.
http://familydoctor.org/620.xml
26.
http://www.emedicine.com/radio/topic565.htm
27. http://www.inciid.org/faq.php?cat=infertility101
28. http:// www.modernmedicine.com
29. http:// www.indiaparenting.com
Received on 17.05.2012 Modified
on 22.05.2012
Accepted
on 25.05.2012 ©
A&V Publication all right reserved
Asian J. Nur. Edu. & Research 2(2): April-June 2012; Page 55-64